Heartland Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Heartland Advisors’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-125,000	Closed	-$1.09M	–	218
2018 Q2	$1.09M	Sell	125,000 -25,000	-17%	-$225K	0.07%	175
2018 Q1	$1.52M	Sell	150,000 -100,000	-40%	-$840K	0.1%	178
2017 Q4	$1.21M	Sell	250,000 -150,000	-38%	-$729K	0.08%	166
2017 Q3	$1.82M	Hold	400,000	–	–	0.12%	163
2017 Q2	$2.02M	Hold	400,000	–	–	0.13%	162
2017 Q1	$1.9M	Hold	400,000	–	–	0.12%	171
2016 Q4	$2.24M	Hold	400,000	–	–	0.12%	167
2016 Q3	$2.22M	Buy	400,000 +113,029	+39%	+$747K	0.13%	164
2016 Q2	$2.01M	Buy	286,971 +73,118	+34%	+$515K	0.11%	164
2016 Q1	$1.41M	Buy	+213,853	New	+$1.57M	0.07%	165

Heartland Advisors's JNP Position: Q3 2018 in Review

Heartland Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 125,000 shares — an estimated $1.09M sold.

Heartland Advisors first reported a position in JNP in Q1 2016 and held it in 10 quarters. The position peaked at $2.24M in Q4 2016. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Heartland Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Heartland Advisors sold 125,000 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $1.09M.
Heartland Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2016 and held it in 10 quarters.
Heartland Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $2.24M in Q4 2016.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Heartland Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.